Abstract:Introduction/Purpose Heart failure (HF) is a serious cardiovascular condition with a significant global health concern. The risk of heart failure rehospitalisation is high globally and locally, the 30-day HF readmission was about 32% from a local study (1). The study aims to adopt an intensive treatment strategy similar to Strong-HF trial (2) and evaluate rapid up-titration of guideline directed medical therapy (GDMT) and close follow-up will improve patients' outcomes after acute heart failure (AHF). Objectives The Reduction of Decompensation and Unnecessary Cardiac failure Emergency admissions: ambulatory Heart Failure service model (REDUCE-HF) is a non-randomised prospective study evaluating clinical outcome of patients discharged from AHF. Exclusion criteria included primary valvular disorders, end-stage renal failure and metastatic cancer. After HF discharge, eligible patients were recruited into our REDUCE-HF program irrespective of LVEF. They were subsequently managed in our ambulatory HF centre within two weeks, where intensive up-titration of GDMT and close follow-up would be proceeded. The data of our service model will be compared with our 5-year historical cohort. Primary outcome comprised of all-cause mortality and heart failure hospitalisation. Secondary outcome will be comparison of clinical and functional status at baseline and 3-month on follow up. Results Between October 2022, and December 2023, 245 patients were successfully recruited into our REDUCE-HF service model. Historical cohort of 6867 patients with primary diagnosis of acute heart failure were served as control (usual care pathway), data extracted from 2018 to 2022. Their mean age was 67.8+/-12.2 and 72.2%were male. 60% of them were HFrEF (EF<=40%) and 28% were ischaemic cardiomyopathy. The mean follow up period was 3 months. At 90 days, REDUCE-HF cohort group has shown much lower all-cause mortality than usual care group (2.5% vs 9.3%, HR 0.26, 95% CI 0.18-0.41, p<0.001). There was a much lower incidence of heart failure hospitalisation in REDUCE-HF group as compared to control (8.6% vs 13.1%, HR 0.65; 95% CI 0.55 to 0.74, p<0.01). In secondary outcome, there was significant reduction of NT-ProBNP of 45.2% (from 4229 to 2319pg/m, p<0.001), tremendous increment of 6-minute walk test (from 211 to 250m, p<0.001) and remarkable improvement of KCCQ score from 55.1 to 86.7, p<0.001. The overall LVEF was significantly increased from 39% to 44%, p<0.05. The positive outcome were attributed to good adherence to GDMT: ACEi/ARB/ARNI 91%, Betablocker 90.3%, MRA 72.4% and SGLT2i 95.5%. Conclusion The REDUCE-HF ambulatory service model has been proven effective in reducing mortality, decompensation and preventing unnecessary heart failure hospitalisation in this prospective study. By intervening proactively, this model not only enhances the quality of life but also hold promise in alleviating the burden of in-patient services on heart failure.

NEW TEST WHICH CAN PREDICT WHICH PATIENT WILL BE READMITTED AFTER HOSPITALIZATION FOR HEART FAILURE

First-phase Ejection Fraction to Predict Adverse Outcomes in Patients with Heart Failure.

Association Between Coronary Artery Disease Testing in Patients with New-Onset Heart Failure and Heart Failure Readmission and Mortality

Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure

Prediction of 90 day readmission in heart failure with preserved ejection fraction by interpretable machine learning

Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year

Heart Failure with Preserved Ejection Fraction: Readmission Outcomes Analysis in A Single Center Registry

Development and Validation of a Machine Learning Model to Predict the Risk of Readmission Within One Year in HFpEF Patients: Short Title: Prediction of HFpEF Readmission

Heart Failure Hospital Readmission Accurately Predicted By Seismocardiography Convolutional Neural Networks Modeling

Development and validation of a predicting model for risk of rehospitalization within 30 days in heart failure patients with preserved ejection fraction

Risk of readmission after heart failure hospitalization in older adults with congenital heart disease

Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure

A nomogram based on a patient-reported outcomes measure: predicting the risk of readmission for patients with chronic heart failure

Abstract 238: Heart Failure: Do We Get With the Guidelines?

Early and short-term intensive management after discharge for patients hospitalized with acute heart failure: a randomized study (ECAD-HF)

Prognostic value of NT-proBNP in the new era of heart failure treatment

A Novel Nomogram to Predict All‐cause Readmission or Death Risk in Chinese Elderly Patients with Heart Failure

Clinical Characteristics and Prognostic Predictors In Hospitalized Heart Failure Patients with Improved Or Preserved Ejection Fraction

Predicting 1 year readmission for heart failure: A comparative study of machine learning and the LACE index

REDUCE-HF: a stronger heart go a long way

Association Between The Discharge Process And Post-Discharge Events In Patients With Heart Failure